Automated radiosynthesis of [18F]PBR111 and [18F]PBR102 using the Tracerlab FXFN and Tracerlab MXFDG module for imaging the peripheral benzodiazepine receptor with PET

Applied Radiation and Isotopes

Volumn 70, Issue 1, 2012, Pages 176-183

  Bourdier, Thomas ^a   Pham, Tien Q ^b   Henderson, David ^a   Jackson, Timothy ^b   Lam, Peter ^a   Izard, Michael ^b   Katsifis, Andrew ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

18F fluorination; 18F PBR102; 18F PBR111; Tracerlab FXFN; Tracerlab MXFDG

Indexed keywords

[18F]FLUORINATION; [18F]PBR102; [18F]PBR111; TRACERLAB FXFN; TRACERLAB MXFDG;

FLUORINE;

2 (6 CHLORO 2 (4 (3 FLUOROETHOXY)PHENYL)IMIDAZO[1.2 A]PYRIDIN 3 YL)N,N DIETHYLACETAMIDE F 18; 2 (6 CHLORO 2 (4 (3 FLUOROPROPOXY)PHENYL)IMIDAZO[1.2 A]PYRIDIN 3 YL)N,N DIETHYLACETAMIDE F 18; 4 TOLUENESULFONYL; BENZODIAZEPINE RECEPTOR; RADIOPHARMACEUTICAL AGENT; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID RECEPTOR; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUORINE; TSPO PROTEIN, HUMAN;

ARTICLE; AUTOANALYZER; AUTOMATION; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SYNTHESIS; EQUIPMENT DESIGN; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN ANALYSIS; RADIATION DOSE; RADIOACTIVITY; RADIOCHEMISTRY; RADIOISOTOPE DECAY; REACTION TIME; CHEMISTRY; HUMAN; INSTRUMENTATION; ISOTOPE LABELING; METHODOLOGY; PROTEIN BINDING; ROBOTICS; SYNTHESIS;

CONTRAST MEDIA; EQUIPMENT DESIGN; FLUORINE RADIOISOTOPES; HUMANS; ISOTOPE LABELING; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTORS, GABA; ROBOTICS;

EID: 80955142826     PISSN: 09698043     EISSN: 18729800     Source Type: Journal    
DOI: 10.1016/j.apradiso.2011.07.014     Document Type: Article

References (18)

1. Anholt R.R., De Souza E.B., Oster-Granite M.L., Snyder S.H. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J. Pharmacol. Exp. Ther. 1985, 233:517-526.
2. 3H]PK11195 to cerebral cortex and peripheral tissues of various species: species differences and heterogeneity in peripheral benzodiazepine binding sites. J. Neurochem. 1987, 49:1407-1414.
3. Banati R.B., Newcombe J., Gunn R.N., Cagnin A., Turkheimer F., Price G., Wegner F., Giovannoni G., Miller D.H., Perkin G.D., Smith T., Hewson A.K., Bydder G., Kreutzberg G.W., Jones T., Cuzner M.L., Myers R. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000, 123:2321-2337.
4. Benavides J., Quarteronet D., Imbault F., Malgouris C., Uzan A., Renault C., Dubroeucq M.C., Gueremy C., Le Fur G. Labelling of peripheral-type benzodiazepine binding sites in the rat brain using PK11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem. 1983, 41:1744-1750.
5. Benavides J., Fage D., Carter C., Scatton B. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res. 1987, 421:167-172.
6. Diorio D., Welner S.A., Butterworth R.F., Meaney M.J., Suranyl-Cadotte B.E. Peripheral benzodiazepine binding sites in Alzheimer's disease frontal cortex and temporal cortex. Neurobiol. Aging 1991, 12:255-258.
7. 18F]PBR111, a selective radioligand for imaging the translocator protein (18kDa) with PET. J. Labelled Compd. Radiopharm. 2008, 51:435-439.
8. 18F]PBR111 in baboons with PET. J. Nucl. Med. 2009, 50(S2):621.
9. 18F]Pyrazolo[1,5-a]pyrimidines for study of peripheral benzodiazepine receptor using positron emission tomography. J. Med. Chem. 2008, 51:3700-3712.
10. Katsifis, A., Fookes, C.J.R., Pham, T.Q., Greguric, I., Mattner, F., 2007. Fluorinated ligands for targeting peripherical benzodiazepine receptors. AUS Patent 2006904617.
11. McGeer E.G., Singh E.A., McGeer P.L. Peripheral-type benzodiazepine binding in Alzheimer's disease. Alzheimer Dis. Assoc. discord. 1988, 2:331-336.
12. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzeimer's disease brains. Neurology 1988, 38:1285-1291.
13. Messmer K., Reynolds G.P. Increased peripheral benzodiazepine binding sites in the brain of patients with Huntingtons disease. Neurosci. Lett. 1998, 241:53-56.
14. Ouchi Y.Y.E. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol. 2005, 57:168-175.
15. 11C]PK11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J. Nucl. Med. 1991, 32:1608-1610.
16. 11C]PK11195. Neurology 2000, 55:1052-1054.
17. 18F]PBR111. J. Nucl. Med. 2009, 50(S 2):1842.
18. Vowinckel E., Reutens D., Becher B., Verge G., Evans A., Owens T., Antel J.P. PK11195 binding the peripheral benzodiazepine receptor as a marker or microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1997, 50:345-353.